(Q44903073)

7 December 2017

Cholesterol lowering effect of dietary weight loss and orlistat treatment--efficacy and limitations (English)

1 reference

7 December 2017

Erdmann J

1

1 reference

7 December 2017

Lippl F

series ordinal

2

1 reference

7 December 2017

Klose G

series ordinal

3

1 reference

7 December 2017

Schusdziarra V

series ordinal

4

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Alimentary Pharmacology & Therapeutics

7 December 2017

1 reference

7 December 2017

19

1 reference

7 December 2017

11

1 reference

7 December 2017

1173-1179

1 reference

The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholester

7 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01966.X

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01966.X

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01966.X

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01966.X

Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01966.X

Relationship between improved postprandial lipemia and low-density lipoprotein metabolism during treatment with tetrahydrolipstatin, a pancreatic lipase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01966.X

Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01966.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01966.X

10.1111/J.1365-2036.2004.01966.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference